News
-
-
PRESS RELEASE
A World-First in Neonatal Care: Japan Approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as a Prescription Drug for Vulnerable Infants
Japan approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as Prescription Drug for Vulnerable Infants, supported by clinical evidence and regulatory milestones -
-
-
-
PRESS RELEASE
JOST implements its growth strategy AMBITION 2030 further and achieves strong results in all business lines in fiscal year 2025
JOST implements its growth strategy AMBITION 2030 further, achieving strong fiscal year 2025 results with 43.5% revenue rise, 28.6% EBIT increase, and record free cash flow -
-
PRESS RELEASE
Iute Group Reports Unaudited Results for 12M/2025 Transformation into Digital Bank Ongoing
Iute Group reports unaudited 12M/2025 results, continuing transformation into digital bank. Revenue growth, decreased cost of risk, and successful bond refinancing. CEO & CFO to discuss results in webcast -
-